Program
※ Please enter the password provided by the secretariat.
The password can be found on page 9 of the Program and Abstracts.
Presidential Lecture
May 24 (Sat.) 12:40～13:10 Room 1(2F Main Hall B・C)
- Chairperson
-
- Hirokazu Murakami
- （Gunma University of Health and Welfare/Japanese Society of Myeloma (JSM) Former President）
20 years of myeloma research - from micro RNA to microenvironment
- Speaker
-
- Hiroshi Handa
- （Department of Hematology, Graduate School of Medicine, Gunma University/Department of Hematology, Gunma University Hospital）
Special Lecture
May 25 (Sun.) 15:05～15:50 Room 1(2F Main Hall B・C)
- Chairperson
-
- Hiroshi Handa
- （Department of Hematology, Graduate School of Medicine, Gunma University/Department of Hematology, Gunma University Hospital）
- Speaker
-
- Hiroyuki Kishi
- （Keio University Graduate School of Media Design）
Advanced Technology Seminar
May 25 (Sun.) 12:50～13:20 Room 1(2F Main Hall B・C)
- Chairperson
-
- Hiroyuki Takamatsu
- （Faculty of Transdisciplinary Sciences for Innovation Kanazawa University）
Next Generation MRD monitoring: clonotypic peptide mass spectrometry
- Speaker
-
- Vincent Bonifay
- （SEBIA）
Symposium
Symposium 1
What are the problems that hinder
the promotion of new drug development in Japan?Presentation Language：Japanese
Slide Language：Japanese
May 24 (Sat.) 9:00～10:20 Room 1(2F Main Hall B・C)
- Chairpersons
-
- Yoshiaki Ohyama
- （Innovative Medical Research Center, Gunma University Hospital, Japan）
- Tomoko Narita
- （Department of Hematology and Oncology, Nagoya City University）
Proposal for Promoting New Drug Development from the Perspective of ARO
- Speaker
-
- Yoshiaki Ohyama
- （Innovative Medical Research Center, Gunma University Hospital, Japan）
Creating Tomorrow's Normal One Step Ahead～Drug Review in Japan～
- Speaker
-
- Yoshinori Imai
- （Pharmaceuticals and Medical Devices Agency）
Current Status and Challenges of Clinical Trials in Japan from Sponsor Perspective
- Speaker
-
- Masayo Miyata
- （Oncology Clinical Operation Department, Global Clinical Operations Japan, Janssen Pharmaceutical K.K.）
Clinical Trial for Patients and the Public – Some Findings from Patient Survey
- Speaker
-
- Kyoko Joko
- （Myeloma Patients and Families, Japan）
Current situation and further issues in the development of novel drugs in plasma cell neoplasms in Japan
- Speaker
-
- Shinsuke Iida
- （Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Japan/Japanese Society of Myeloma (JSM) President）
- Panelist
-
- Toyotaka Iguchi
- （Pharmaceuticals and Medical Devices Agency）
Symposium 2
How to Advance Genomic Medicine in MyelomaPresentation Language：Japanese
Slide Language：English
May 24 (Sat.) 10:30～11:30 Room 1(2F Main Hall B・C)
- Chairpersons
-
- Hirohiko Shibayama
- （Department of Hematology, NHO Osaka National Hospital）
- Sho Ikeda
- （Akita University）
Clinical utility of comprehensive genomic profiling for hematologic malignancies
- Speaker
-
- Keisuke Kataoka
- （Division of Hematology, Department of Medicine, Keio University School of Medicine/Division of Molecular Oncology, National Cancer Center Research Institute）
Genomic abnormalities of multiple myeloma in a Japanese population: current and future status of gene panel testing
- Speaker
-
- Masaki Ri
- （Department of Hematology and Oncology, Graduate school of medical sciences, Nagoya City University, Japan）
Genetic analysis of multiple myeloma using circulating tumor DNA
- Speaker
-
- Yasunori Kogure
- （Division of Molecular Oncology, National Cancer Center Research Institute, Japan）
Symposium 3
International Symposium:
How to proceed myeloma treatment
and research in international collaborationPresentation Language：English
Slide Language：English
May 24 (Sat.) 13:50～14:50 Room 1(2F Main Hall B・C)
- Chairpersons
-
- Chiaki Nakaseko
- （International University of Health and Welfare）
- Hiroshi Kosugi
- （Department of Hematology, Ogaki Municipal Hospital）
Recent advancement and future perspective of myeloma treatmentPre-recorded Video
- Speaker
-
- Philippe Moreau
- （University Hospital, Nantes, France/President of the International Myeloma Society (IMS)）
The Asian Myeloma Network: Past, Present and Future
- Speaker
-
- Wee Joo Chng
- （National University Cancer Institute, Singapore/Chairperson of the Asian Myeloma Network (AMN)）
JSM initiatives: from internationalization to international contribution
- Speaker
-
- Masahiro Abe
- （Department of Hematology, Kawashima Hospital/Japanese Society of Myeloma (JSM) Former President）
Symposium 4
Current Status and Issues
in Promoting Physician-Initiated Clinical ResearchPresentation Language：Japanese
Slide Language：Japanese
May 25 (Sun.) 9:00～10:20 Room 1(2F Main Hall B・C)
- Chairpersons
-
- Junya Kuroda
- （Graduate School of Medical Science, Kyoto Prefectural University of Medicine）
- Shuji Ozaki
- （Tokushima Prefectural Central Hospital）
Clinical trials for multiple myeloma of Japan Study Group for Cell Therapy and Transplantation
- Speaker
-
- Tomohiko Kamimura
- （Harasanshin Hospital/Japan Study Group for Cell Therapy and Transplantation）
Clinical trials for multiple myeloma in Japan Clinical Oncology Group
- Speaker
-
- Dai Maruyama
- （Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research）
Experience of JSH-MM-15 trial
- Speaker
-
- Hirohiko Shibayama
- （Department of Hematology, NHO Osaka National Hospital）
The Kansai Myeloma Forum: 13 Years of Progress
- Speaker
-
- Teruhito Takakuwa
- （Department of Hematology, Wakakusa Daiichi Hospital）
The History and Achievements of Clinical Research at KTMM (Kanto-Tohoku Multiple Myeloma Conference)
- Speaker
-
- Hideto Tamura
- （Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center/Department of Hematology, Nippon Medical School）
Symposium 5
Immune cell therapy (CAR-T/Bispecific antibody)Presentation Language：English
Slide Language：English
May 25 (Sun.) 13:30～15:00 Room 1(2F Main Hall B・C)
- Chairpersons
-
- Hideto Tamura
- （Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center）
- Naoya Mimura
- （Graduate School of Medicine, Chiba University）
Optimal Sequence of immunotherapy (CAR-T, bispecific antibodies)Pre-recorded Video
- Speaker
-
- Philippe Moreau
- （University Hospital, Nantes, France/President of the International Myeloma Society (IMS)）
Resistant mechanism of immunotherapy, by immune microenvironment change
- Speaker
-
- Nizar Jacqued Bahlis
- （University of Calgary）
Enhancing CAR-T cell efficacy based on molecular mechanisms of dysfunction
- Speaker
-
- Yuki Kagoya
- （Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine, Japan）
Identification of New Target Antigens for CAR-T Cell Therapy Against Multiple Myeloma
- Speaker
-
- Naoki Hosen
- （Dept. of Hematology and Oncology, Osaka University Graduate School of Medicine）
Symposium 6
How to proceed Interprofessional work
and regional cooperation
for multiple myeloma treatmentPresentation Language：Japanese
Slide Language：Japanese
May 25 (Sun.) 13:50～15:00 Room 2(2F Main Hall A)
- Chairpersons
-
- Emiko Sakaida
- （Chiba University Hospital）
- Kazuhito Suzuki
- （Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine）
Advances in myeloma treatment and the importance of regional collaboration: The Perspective of a Regional Core Hospital
- Speaker
-
- Kyoko Yoshihara
- （Department of Hematology, Hyogo Medical University Hospital）
A Sustainable Multiple Myeloma Care System through Collaboration between Hematology and Oncology Centers and Primary Care Clinics
- Speaker
-
- Atsushi Isoda
- （Medical Corporation Hoshi Clinic）
Supporting the livｅｓ of multiple myeloma patients as a team～From the point of view of nursing～
- Speaker
-
- Masako Honda
- （Department of Nursing, Shibukawa Medical Center, Shibukawa, Gunma, Japan）
The Role of Pharmacists in Multiple Myeloma Treatment: The Importance of Multidisciplinary and Regional Collaboration
- Speaker
-
- Komuro Masato
- （Center for Medical Informatics Intelligence, National Center for Global Health and Medicine）
What Patients Mean by Collaboration across Professions and Regions
- Speaker
-
- Joko Kyoko
- （Myeloma Patients and Families, Japan）
Oral Session
Oral Session 1
Basic research 1Presentation Language：Japanese or English
Slide Language：English
May 24 (Sat.) 9:00～10:20 Room 2(2F Main Hall A)
- Chairpersons
-
- Takeshi Harada
- （Department of Hematology, Endocrinology and Metabolism, Tokushima University）
- Mariko Ishibashi
- （Department of Microbiology and Immunology, Nippon Medical School）
Oral Session 2
Biomarker and Related DisordersPresentation Language：Japanese or English
Slide Language：English
May 24 (Sat.) 10:30～11:30 Room 2(2F Main Hall A)
- Chairpersons
-
- Ichiro Hanamura
- （Division of Hematology, Department of Internal Medicine, Aichi Medical University）
- Yawara Kawano
- （Department of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University）
Oral Session 3
TreatmentPresentation Language：Japanese or English
Slide Language：English
May 24 (Sat.) 13:40～14:50 Room 2(2F Main Hall A)
- Chairpersons
-
- Kazutaka Sunami
- （NHO Okayama Medical Center）
- Nobuhiro Tsukada
- （Department of Hematology, Japanese Red Cross Medical Center）
Oral Session 4
Basic research 2Presentation Language：Japanese or English
Slide Language：English
May 25 (Sun.) 10:30～11:40 Room 1(2F Main Hall B・C)
- Chairpersons
-
- Yoichi Imai
- （Dokkyo Medical University）
- Michiko Ichii
- （Department of Hematology and Oncology, Graduate School of Medicine, The University of Osaka）
Oral Session 5
Complications, Rehabilitation
and MultidisciplinaryPresentation Language：Japanese or English
Slide Language：Japanese or English
May 25 (Sun.) 9:00～9:50 Room 2(2F Main Hall A)
- Chairpersons
-
- Shinichi Fuchida
- （JCHO Kyoto Kuramaguchi Medical Center）
- Hirono Iriuchishima
- （NHO Shibukawa Medical Center）
Oral Session 6
New treatment CAR-T etc.Presentation Language：Japanese or English
Slide Language：English
May 25 (Sun.) 9:55～10:45 Room 2(2F Main Hall A)
- Chairpersons
-
- Makoto Sasaki
- （Division of Hematology, Juntendo University）
- Masaki Ri
- （Department of Hematology and Oncology, Nagoya City University）
Oral Session 7
EncorePresentation Language：Japanese or English
Slide Language：English
May 25 (Sun.) 10:50～11:40 Room 2(2F Main Hall A)
- Chairpersons
-
- Yasuhito Terui
- （Department of Hematology, Saitama Medical University Hospital）
- Masuzu Ueda
- （Division of Hematology, Department of Internal Medicine）
Poster Session
May 24 (Sat.) 17:00～18:00 Poster Room
Poster Session 1
Case discussionPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room1(3F Small Conference Room 303)
- Chairpersons
-
- Toru Kiguchi
- （Dokkyo Medical University Saitama Medical Center）
- Tsutomu Kobayashi
- （Japanese Red Cross Kyoto Daiichi Hospital）
Poster Session 2
Multidisciplinary collaborationPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room2(3F Medium Conference Room 301)
- Chairperson
-
- Hideo Yagi
- （Hematology and Oncology, Nara Prefectural General Medical Center）
Poster Session 3
Case ReportPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room2(3F Medium Conference Room 301)
- Chairperson
-
- Chikako Ohwada
- （International University of Health and Welfare）
Poster Session 4
Complications and otherPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room3(3F Medium Conference Room 302)
- Chairperson
-
- Hirokazu Miki
- （Tokushima University Hospital）
Poster Session 5
Elranatamab 1Presentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room3(3F Medium Conference Room 302)
- Chairperson
-
- Takahiro Kobayashi
- （Akita University Department of hematology）
Poster Session 6
Elranatamab 2Presentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room3(3F Medium Conference Room 302)
- Chairperson
-
- Rikio Suzuki
- （Department of Hematology/Oncology, Tokai University School of Medicine）
Poster Session 7
Myeloma basic researchPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room4(2F Medium Conference Room 202)
- Chairperson
-
- Hiroto Ohguchi
- （IRDA, Kumamoto University）
Poster Session 8
First line treatment of myelomaPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room4(2F Medium Conference Room 202)
- Chairperson
-
- Eri Kawata
- （Department of Hematology, Japanese Red Cross Kyoto Daini）
Poster Session 9
Treatment of relapsed,
Refractory myeloma and CAR-T therapyPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room4(2F Medium Conference Room 202)
- Chairperson
-
- Yuji Shimura
- （Division of Hematology and Oncology, Kyoto Prefectural University of Medicine）
Poster Session 10
Test, Diagnosis and BiomarkerPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room4(2F Medium Conference Room 202)
- Chairperson
-
- Hiroshi Yasui
- （Department of Hematology and Oncology, St. Marianna University School of Medicine）
Poster Session 11
Myeloma-related disordersPresentation Language：Japanese or English
Slide Language：Japanese or English
Poster Room4(2F Medium Conference Room 202)
- Chairperson
-
- Shokichi Tsukamoto
- （Department of Hematology, Chiba University Hospital）
Pre-Opening Seminar
Pre-Opening Seminar
Treatment strategies for NDMM and RRMM
May 24 (Sat.) 8:00～8:40 Room 1(2F Main Hall B・C)
Sponsored by Janssen Pharmaceutical K.K. , Medical Affairs Division
- Chairperson
-
- Yasushi Takamatsu
- （Fukuoka University）
Daratumumab is still standard of care as the early line treatment for myeloma
- Speaker
-
- Kazuhito Suzuki
- （Division of Clinical Oncology and Hematology, The Jikei University School of Medicine）
Clinical significance of bispecific antibodies targeting BCMA in relapsed/refractory multiple myeloma
- Speaker
-
- Akihiro Kitadate
- （Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan）
Sponsored Seminar
Sponsored Seminar 1
The Use of Sarclisa in NDMM: Considerations from Basic and Clinical Perspectives
May 24 (Sat.) 15:00～15:50 Room 1(2F Main Hall B・C)
Sponsored by Sanofi K.K.
- Chairperson
-
- Itaru Matsumura
- （Fukuoka University）
Molecular basis of the synergism of isatuximab and VRd in newly-diagnosed multiple myeloma
- Speaker
-
- Yusuke Furukawa
- （Center for Medical Education, Teikyo University of Science/Center for Molecular Medicine, Jichi Medical University）
How to use the isatuximab-based regimens -From basic and clinical standpoints-
- Speaker
-
- Kenshi Suzuki
- （Japanese Red Cross Medical Center）
Sponsored Seminar 2
May 24 (Sat.) 15:00～15:50 Room 2(2F Main Hall A)
Sponsored by CSL Behring K.K.
- Chairperson
-
- Youichi Imai
- （Dokkyo Medical University）
Latest Treatment Strategies for Multiple Myeloma and Infection Management Focusing on Hypogammaglobulinemia
- Speaker
-
- Kentaro Serizawa
- （Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University Hospital）
Sponsored Seminar 3
May 25 (Sun.) 12:50～13:40 Room 2(2F Main Hall A)
Sponsored by Takeda Pharmaceutical Co., Ltd.
- Chairperson
-
- Sakaida Emiko
- （Chiba University Hospital）
The Role of Novel Modalities (CAR-T/BsAb) and Gamma Globulin Preparations in the Treatment of Multiple Myeloma
- Speaker
-
- Yoshiaki Kuroda
- （Department of Hematology, NHO Hiroshimanishi Medical Center）
Morning Seminar
Morning Seminar 1
May 25 (Sun.) 8:00～8:40 Room 1(2F Main Hall B・C)
Sponsored by Ono Pharmaceutical Co., Ltd.
- Chairperson
-
- Shibayama Hirohiko
- （NHO Osaka National Hospital）
Diagnostic and therapeutic approaches for Waldenström's macroglobulinemia and lymphoplasmacytic lymphoma based on real world clinical experience
- Speaker
-
- Kohei Okada
- （Sapporo Hokuyu Hospital Hematology）
Morning Seminar 2
May 25 (Sun.) 8:00～8:40 Room 2(2F Main Hall A)
Sponsored by SEBIA JAPAN K.K.
- Chairperson
-
- Shuji Ozaki
- （Tokushima University Hospital）
Multiple Myeloma Diagnostics Testing and Treatment Up to Date
- Speaker
-
- Tadao Ishida
- （Director of Myeloma and Amyloidosis Center, Japanese Red Cross Medical Center）
Luncheon Seminar
Luncheon Seminar 1
Reconsidering the Role of Proteasom Inhibitors in the Immunotherapy Era
May 23 (Fri.) 12:00～12:50 Room 2(2F Main Hall A)
Sponsored by Ono Pharmaceutical Co., Ltd.
- Chairperson
-
- Nobuhiro Tsukada
- （Japanese Red Cross Medical Center）
The role of carfilzomib in relapsed and refractory multiple myeloma: a basic research perspective
- Speaker
-
- Kentaro Serizawa
- （Department of Hematology and Rheumatology,Kindai University Faculty of Medicine）
Role of carfilzomib for relapsed/refractory multiple myeloma in the immunotherapy era：discussion based on our case experience
- Speaker
-
- Masuho Saburi
- （Department of Hematology, Oita Prefectural Hospital）
Luncheon Seminar 2
Treatment Strategy for Relapsed and Refractory Multiple Myeloma
May 24 (Sat.) 11:40～12:30 Room 1(2F Main Hall B・C)
Sponsored by Janssen Pharmaceutical K.K.
- Chairperson
-
- Hiroshi Handa
- （Department of Hematology, Graduate School of Medicine, Gunma University/Department of Hematology, Gunma University Hospital）
Teclistamab for the treatment of patients with relapsed/refractory multiple myelomaPre-recorded Video
- Speaker
-
- Philippe Moreau
- （University Hospital of Nantes, France）
Where to use bispecific antibodies in clinical practice
- Consideration based on the immune environment and clinical studies in Japanese –
- Speaker
-
- Hideto Tamura
- （Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center/Department of Hematology, Nippon Medical School）
Luncheon Seminar 3
May 24 (Sat.) 11:40～12:30 Room 2(2F Main Hall A)
Sponsored by Pfizer Japan Inc.
- Chairperson
-
- Shinsuke Iida
- （Nagoya City University）
New therapeutic strategies for relapsed/refractory multiple myeloma
- Speaker
-
- Tadao Ishida
- （Director of the Department of Hematology/Director of the Myeloma and Amyloidosis Center, Japanese Red Cross Medical Center）
Luncheon Seminar 4
Three years have passed since the launch of Ide-cel, and what changes have been observed in clinical practice?
May 25 (Sun.) 11:50～12:40 Room 1(2F Main Hall B・C)
Sponsored by Bristol-Myers Squibb K.K.
- Chairperson
-
- Sunami Kazutaka
- （NHO Okayama Medical Center）
Updating the Myeloma Treatment Sequence: Three Years of Experience with Ide-cel
- Speaker
-
- Satoshi Yoshihara
- （Department of Respiratory Medicine and Hematology, Hyogo Medical University）
Luncheon Seminar 5
May 25 (Sun.) 11:50～12:40 Room 2(2F Main Hall A)
Sponsored by Pfizer Japan Inc. Medical Affairs
- Chairperson
-
- Hiroshi Handa
- （Associate Professor and Director, Department of Hematology,Graduate School of Medicine, Gunma University/ Clinical Professor and Division Chief, Department of Hematology,Gunma University Hospital ）
What is the optimal treatment for relapsed refractory multiple myeloma?
- Speaker
-
- Nizar Jacques Bahlis
- （Associate Professor, Arnie Charbonneau Cancer Institute, University of Calgary）
Evening Seminar
Evening Seminar 1
How to prevent herpes zoster in myeloma
May 23 (Fri.) 16:10～17:00 Room 1(2F Main Hall B・C)
Sponsored by GlaxoSmithKline K.K.
- Chairperson
-
- Emiko Sakaida
- Chiba University Hospital
Prevention of infectious diseases in BCMA Targeted Therapy for Multiple Myeloma
- Speaker
-
- Yoshiaki Kuroda
- （Department of Hematology, National Hospital Organization Hiroshima-Nishi Medical Center）
How to prevent varicella zoster virus reactivation in myeloma
- Speaker
-
- Kazuhito Suzuki
- （Division of Clinical Oncology and Hematology, The Jikei University School of Medicine）
Evening Seminar 2
CLL
May 23 (Fri.) 16:10～17:00 Room 2(2F Main Hall A)
Sponsored by BeiGene, Inc.
- Chairperson
-
- Shinsuke Iida
- （Nagoya City University）
The impact of BTK inhibitor for Waldenström’s macroglobulinemia -through the ASPEN trial-
- Speaker
-
- Naohiro Sekiguchi
- （Department of Hematology, National Hospital Organization Disaster Medical Center）
Evening Seminar 3
Treatment Strategies for Multiple Myeloma Considered from Basic and Clinical Perspectives
May 24 (Sat.) 16:00～16:50 Room 1(2F Main Hall B・C)
Sponsored by Janssen Pharmaceutical K.K.
- Chairperson
-
- Junya Kuroda
- （Kyoto Prefectural University of Medicine）
Overview of the Fundamentals of Immunotherapies for Multiple Myeloma and Current Issues
- Speaker
-
- Daisuke Ogiya
- （Department of Hematology and Oncology, Tokai University School of Medicine）
Shaping the Future of First-Line Treatment for Transplant-Ineligible Myeloma Patients
- Speaker
-
- Yuichi Horigome
- （Department of Hematology, Kitasato University Hospital, Japan）
Evening Seminar 4
May 24 (Sat.) 16:00～16:50 Room 2(2F Main Hall A)
Sponsored by Takeda Pharmaceutical Co., Ltd.
- Chairperson
-
- Shigeki Ito
- （Iwate Medical University School of Medicine）
Multiple myeloma treatment strategies with a focus on patient well-being - The significance of maintenance therapy in an era of MM treatment progress -
- Speaker
-
- Takashi Ikeda
- （Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan）